Efficacy and Safety of Ribociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR-Positive/HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors

Bishal Paudel
Simit Sapkota (ORCID: https://orcid.org/0000-0002-6290-4318)
Parikshit Prasai
Sunil Shrestha (ORCID: https://orcid.org/0000-0002-9174-7120)
Kamal Ranabhat (ORCID: https://orcid.org/0000-0002-6872-254X)
Reechashree Dhungana (ORCID: https://orcid.org/0009-0005-9151-2064)

Institutions

Tribhuvan University (NP)
Ministry of Health and Population (NP)
Eastern Health (AU)
Tribhuvan University Teaching Hospital (NP)
Primary Health Care (QA)
Nepal Academy of Science and Technology (NP)

Publication Details

Journal: Clinical Medicine Insights Oncology
Published: 2025-01-01
DOI: https://doi.org/10.1177/11795549251402955
Primary Topic: Advanced Breast Cancer Therapies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and Safety of Ribociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR-Positive/HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Bishal Paudel, Simit Sapkota, Parikshit Prasai, Sunil Shrestha et al.

Jan 1, 2025

Clinical Medicine Insights Oncology

Advanced Breast Cancer Therapies

article

Efficacy and Safety of Ribociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR-Positive/HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Bishal Paudel, Simit Sapkota, Parikshit Prasai, Sunil Shrestha, Kamal Ranabhat, Reechashree Dhungana

January 1, 2025article en

Abstract

No abstract available for this paper.

Clinical Medicine Insights OncologyVol. 19

Tribhuvan University (NP), Ministry of Health and Population (NP), Eastern Health (AU), Tribhuvan University Teaching Hospital (NP), Primary Health Care (QA), Nepal Academy of Science and Technology (NP)

Openalex Percentile: Top 40%

Advanced Breast Cancer Therapies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and Safety of Ribociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR-Positive/HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Bishal Paudel, Simit Sapkota, et al. · Clinical Medicine Insights Oncology (2025) | TGRS Research Map | TGRS